Polymorphism of human cytochrome P450 enzymes and its clinical impact
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Authors
Keywords
-
Journal
DRUG METABOLISM REVIEWS
Volume 41, Issue 2, Pages 89-295
Publisher
Informa UK Limited
Online
2009-05-07
DOI
10.1080/03602530902843483
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacogenetics of Tamoxifen: Who Should UndergoCYP2D6Genetic Testing?
- (2017) Michaela J. Higgins et al. Journal of the National Comprehensive Cancer Network
- Role of CYP2B6 in Stereoselective Human Methadone Metabolism
- (2009) Rheem A. Totah et al. ANESTHESIOLOGY
- Two Novel CYP2D6*10 Haplotypes As Possible Causes of a Poor Metabolic Phenotype in Japanese
- (2009) M. Matsunaga et al. DRUG METABOLISM AND DISPOSITION
- Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
- (2009) David A Flockhart et al. GENETICS IN MEDICINE
- Effects of the CYP2D6 Gene Duplication on the Pharmacokinetics and Pharmacodynamics of Tramadol
- (2009) Julia Kirchheiner et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- CYP2D6 Polymorphism in Relation to Tramadol Metabolism: A Study of Faroese Patients
- (2009) Jónrit Halling et al. THERAPEUTIC DRUG MONITORING
- Influence of Comedication on Serum Concentrations of Aripiprazole and Dehydroaripiprazole
- (2009) Ragnhild Birkeland Waade et al. THERAPEUTIC DRUG MONITORING
- Clinical profile of prasugrel, a novel thienopyridine
- (2008) Dominick J. Angiolillo et al. AMERICAN HEART JOURNAL
- Prasugrel: A novel antiplatelet agent
- (2008) A. B. Riley et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment
- (2008) Y. Xu et al. ANNALS OF ONCOLOGY
- Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients
- (2008) Jung-Ryul Kim et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of CYP2C19 *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians
- (2008) Nicole G. Hunfeld et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants
- (2008) Monique J. Bijl et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa
- (2008) Corine Ekhart et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Polymorphisms in Genes Involved in Sex Hormone Metabolism, Estrogen Plus Progestin Hormone Therapy Use, and Risk of Postmenopausal Breast Cancer
- (2008) B. Diergaarde et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1
- (2008) Ken-ichi Fujita et al. CANCER SCIENCE
- Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy
- (2008) Kazuma Kiyotani et al. CANCER SCIENCE
- Stereoselective Disposition of Proton??Pump Inhibitors
- (2008) Tommy Andersson et al. CLINICAL DRUG INVESTIGATION
- CYP2D6 Phenotype Prediction From Genotype: Which System Is the Best?
- (2008) J Kirchheiner CLINICAL PHARMACOLOGY & THERAPEUTICS
- The CYP3A4*18 Genotype in the Cytochrome P450 3A4 Gene, a Rapid Metabolizer of Sex Steroids, Is Associated With Low Bone Mineral Density
- (2008) YS Kang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study
- (2008) P Madadi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacology of Nicotine: Implications for Understanding, Preventing, and Treating Tobacco Addiction
- (2008) NL Benowitz CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β-Blocker Users
- (2008) MJ Bijl et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics and Potential Application in Personalized Medicine
- (2008) Shu-Feng Zhou et al. CURRENT DRUG METABOLISM
- Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4
- (2008) Shu-Feng Zhou CURRENT DRUG METABOLISM
- Metabolism of Atypical Antipsychotics: Involvement of Cytochrome P450 Enzymes and Relevance for Drug-Drug Interactions
- (2008) Liana Urichuk et al. CURRENT DRUG METABOLISM
- Type 2 Diabetes and Oral Antihyperglycemic Drugs
- (2008) Mitchell Avery et al. CURRENT MEDICINAL CHEMISTRY
- Erhöhte Flecainid-Plasmakonzentrationen bei Herzinsuffizienz*
- (2008) J. Nitsch et al. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
- In Vitro Metabolism of 2-[6-(4-Chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl] Acetic Acid (Licofelone, ML3000), an Inhibitor of Cyclooxygenase-1 and -2 and 5-Lipoxygenase
- (2008) W. Albrecht et al. DRUG METABOLISM AND DISPOSITION
- Characterization of CYP2A13*2, a Variant Cytochrome P450 Allele Previously Found to Be Associated with Decreased Incidences of Lung Adenocarcinoma in Smokers
- (2008) J. D'Agostino et al. DRUG METABOLISM AND DISPOSITION
- An in Vitro Mechanistic Study to Elucidate the Desipramine/Bupropion Clinical Drug-Drug Interaction
- (2008) M. J. Reese et al. DRUG METABOLISM AND DISPOSITION
- Expression and Functional Analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 Isozymes
- (2008) W.-Y. Zhang et al. DRUG METABOLISM AND DISPOSITION
- Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57)
- (2008) K. Sakuyama et al. DRUG METABOLISM AND DISPOSITION
- Role of Flavin-Containing Monooxygenase in Oxidative Metabolism of Voriconazole by Human Liver Microsomes
- (2008) S. B. Yanni et al. DRUG METABOLISM AND DISPOSITION
- Generation of Mice Transgenic for Human CYP2C18 and CYP2C19: Characterization of the Sexually Dimorphic Gene and Enzyme Expression
- (2008) S. Lofgren et al. DRUG METABOLISM AND DISPOSITION
- The Biotransformation of Prasugrel, a New Thienopyridine Prodrug, by the Human Carboxylesterases 1 and 2
- (2008) E. T. Williams et al. DRUG METABOLISM AND DISPOSITION
- Bupropion
- (2008) Sohita Dhillon et al. DRUGS
- Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients
- (2008) Petra Bohanec Grabar et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements
- (2008) Andrea Gaedigk et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele
- (2008) M. Hermann et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Chronic heart failure: β-blockers and pharmacogenetics
- (2008) Junichi Azuma et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individual
- (2008) Andrea Gaedigk et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pantoprazole: from drug metabolism to clinical relevance
- (2008) Marc Bardou et al. Expert Opinion on Drug Metabolism & Toxicology
- Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on G×E interactions and pathogenic pathways
- (2008) Hui-Ju Tsai et al. HUMAN GENETICS
- Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent
- (2008) Jill C. Mwenifumbo et al. HUMAN MUTATION
- Genetic Variations of CYP2C9 in 724 Japanese Individuals and Their Impact on the Antihypertensive Effects of Losartan
- (2008) Tong YIN et al. HYPERTENSION RESEARCH
- Antiretroviral Treatment of Adult HIV Infection
- (2008) Scott M. Hammer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Bright Light and Melatonin on Cognitive and Noncognitive Function in Elderly Residents of Group Care Facilities
- (2008) Rixt F. Riemersma-van der Lek JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients
- (2008) C. Wyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Different Effects ofSLCO1B1Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide
- (2008) Annikka Kalliokoski et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Effect of Oral Contraceptives on the Pharmacokinetics of Melatonin in Healthy Subjects WithCYP1A2g.-163C>A Polymorphism
- (2008) Johanna Hilli et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Stereoselective Bupropion Hydroxylation as an In Vivo Phenotypic Probe for Cytochrome P4502B6 (CYP2B6) Activity
- (2008) Evan D. Kharasch et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver
- (2008) M. H. Hofmann et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6)
- (2008) T. Erkinjuntti et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities
- (2008) A. L. FRELINGER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Novel CYP2C9 Promoter Variants and Assessment of Their Impact on Gene Expression
- (2008) M. A. Kramer et al. MOLECULAR PHARMACOLOGY
- Chemotherapy-Induced Nausea and Vomiting
- (2008) Paul J. Hesketh NEW ENGLAND JOURNAL OF MEDICINE
- Genetic polymorphisms of CYP2A6 affect the in-vivo pharmacokinetics of pilocarpine
- (2008) Takuro Endo et al. Pharmacogenetics and Genomics
- A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent
- (2008) Man Ki Ho et al. Pharmacogenetics and Genomics
- Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide
- (2008) Corine Ekhart et al. Pharmacogenetics and Genomics
- Impact of genetic polymorphisms inCYP2C8and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids
- (2008) Julia Kirchheiner et al. PHARMACOGENOMICS
- Impact ofCYP2C19polymorphisms on the efficacy of clobazam therapy
- (2008) Takayuki Seo et al. PHARMACOGENOMICS
- CYP2A6polymorphisms and risk for tobacco-related cancers
- (2008) Ana Rossini et al. PHARMACOGENOMICS
- Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
- (2008) Arzu Gunes et al. PHARMACOGENOMICS
- Genetic polymorphism analysis ofCYP2C19in Chinese Han populations from different geographic areas of mainland China
- (2008) Lingling Chen et al. PHARMACOGENOMICS
- Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity
- (2008) Adrián LLerena et al. PHARMACOGENOMICS
- Genetic Testing for Warfarin Dosing? Not Yet Ready for Prime Time
- (2008) Henry I Bussey et al. PHARMACOTHERAPY
- The active metabolite of prasugrel effectively blocks the platelet P2Y12receptor and inhibits procoagulant and pro-inflammatory platelet responses
- (2008) Heather M. Judge et al. PLATELETS
- Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample
- (2008) Eric J. Peters et al. PLoS One
- Protective Interventions to Prevent Aflatoxin-Induced Carcinogenesis in Developing Countries
- (2007) John D. Groopman et al. Annual Review of Public Health
- Pharmacokinetics of riluzole: evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype
- (2007) H. J. M. van Kan et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population
- (2007) Jónrit Halling et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Potential Mechanisms of Estrogen Quinone Carcinogenesis
- (2007) Judy L. Bolton et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Prasugrel, a New Thienopyridine Antiplatelet Drug, Weakly Inhibits Cytochrome P450 2B6 in Humans
- (2007) Nag A. Farid et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Plasma concentration of rabeprazole after 8-week administration in gastroesophageal reflux disease patients and intragastric pH elevation
- (2007) Hiro-o Yamano et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: A meta-analysis
- (2007) Xiuquan Shi et al. LUNG CANCER
- Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine
- (2003) Ole V. Olesen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Involvement of human liver cytochrome P4502B6in the metabolism of propofol
- (2003) Yutaka Oda et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started